נבנק

Land: Israel

Sprache: Hebräisch

Quelle: Ministry of Health

Kaufe es jetzt

Gebrauchsinformation Gebrauchsinformation (PIL)
10-08-2022

Wirkstoff:

NEPAFENAC

Verfügbar ab:

NOVARTIS ISRAEL LTD

ATC-Code:

S01BC10

Darreichungsform:

תרחיף לעין

Zusammensetzung:

NEPAFENAC 0.1 %

Verabreichungsweg:

עיני

Verschreibungstyp:

מרשם נדרש

Hergestellt von:

ALCON COUVREUR N.V., BELGIUM

Therapiegruppe:

NEPAFENAC

Therapiebereich:

NEPAFENAC

Anwendungsgebiete:

Prevention and treatment of postoperative pain and inflammation associated with cataract surgery and reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.

Berechtigungsdatum:

2015-05-31

Gebrauchsinformation

                                PATIENT PACKAGE INSERT IN ACCORDANCE
WITH THE PHARMACISTS’ REGULATIONS
(PREPARATIONS) - 1986
The medicine is dispensed with
a doctor’s prescription only
NEVANAC
®
EYE DROPS, SUSPENSION
ACTIVE INGREDIENT: NEPAFENAC 1mg/ml 0.1%.
Inactive and allergenic ingredients in the preparation:
Refer to section 6 “Further information” and to section
2 “Important information about some of the ingredients
of the medicine”.
READ THIS LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE
USING THE MEDICINE. This leaflet contains concise
information about the medicine.
If you have further questions, refer to the doctor or
pharmacist.
This medicine has been prescribed for you. Do not
pass it on to others. It may harm them, even if it seems
to you that their medical condition is similar to yours.
1. WHAT IS THE MEDICINE INTENDED FOR?
The medicine is intended for the treatment of adults:
- For prevention and treatment of eye pain and
inflammation following cataract surgery.
- To reduce the risk of development of macular
edema (swelling in the posterior segment of the eye)
following cataract surgery in diabetic patients.
THERAPEUTIC GROUP: non-steroidal anti-inflammatory
drugs (NSAIDs)
2. BEFORE USING THE MEDICINE
DO NOT USE THE MEDICINE IF:
• You are sensitive (allergic) to the active ingredient
nepafenac or to any of the additional ingredients
contained in the medicine (appearing in section 6).
• You are sensitive (allergic) to other non-steroidal
anti-inflammatory drugs (NSAIDs).
• You have suffered in the past from asthma, skin
allergy or severe inflammation in the nose when
using other preparations from the non-steroidal
anti-inflammatory drug (NSAID) group such
as: acetylsalicylic acid, ibuprofen, ketoprofen,
piroxicam, diclofenac.
SPECIAL WARNINGS REGARDING USE OF THE MEDICINE
BEFORE BEGINNING TREATMENT WITH NEVANAC, TELL THE
DOCTOR IF:
• you bruise easily or suffer from bleeding problems,
or have suffered from them in the past.
• you have other eye problems (such as eye infection)
or if you are taking other medicines
                                
                                Lesen Sie das vollständige Dokument
                                
                            

Dokumente in anderen Sprachen

Gebrauchsinformation Gebrauchsinformation Englisch 10-08-2022
Fachinformation Fachinformation Englisch 01-06-2022
Gebrauchsinformation Gebrauchsinformation Arabisch 10-08-2022

Suchen Sie nach Benachrichtigungen zu diesem Produkt

Dokumentverlauf anzeigen